secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001104659-25-008127
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar receives Nasdaq minimum bid price deficiency notice; 180-day cure period until July 29, 2025
--------------------------------------------------------------------------------

- Notice from Nasdaq on Jan 30, 2025 for failure to maintain $1.00 minimum bid price per Nasdaq Listing Rule 5550(a)(2).
- No immediate impact on listing; common stock remains on Nasdaq Capital Market.
- Company has 180 calendar days, until July 29, 2025, to regain compliance.
- If not cured, Company may be eligible for an additional 180-day extension subject to meeting other listing standards.
- Failure to regain compliance could lead to delisting; Company may request a hearing to stay any delisting action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925008127/0001104659-25-008127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925008127/tm255128d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-008127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer